Adjuvant Imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: A median follow-up of 44 months

✍ Scribed by Wei-Zhong Jiang; Guo-Xian Guan; Hui-Shan Lu; Ying-Hong Yang; De-Yong Kang; He-Guang Huang

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 157 KB
• Volume: 104
• Category: Article
• ISSN: 0022-4790
• DOI: 10.1002/jso.22010